In this later study, PSA was able to stimulate the expression of Foxp3 in CD4+ T cells sorted from PBMCs of healthy untreated MS patients, and MS under treatment with glatiramer acetate (GA) when compared to untreated cells. The gene discussed is CD4; the disease is myeloid sarcoma.